Home > Insider Trading > Filing (0001562180-19-005523)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1070336	Achillion Pharmaceuticals Inc	ACHN	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1378585	David Scheer	C/O Achillion Pharmaceuticals, Inc. 1777 Sentry Parkway W, Bldg 14, Ste 200 Blue Bell PA 19422		No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-11-13	20,000	$3.28	40,000	No	4	M	Direct
Common Stock	Disposition	2019-11-13	10,485	$6.31	29,515	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2019-11-13	20,000	$0.00	20,000	$3.28

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2019-12-18	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	63,249	Indirect	See footnote

Footnotes

Consists of shares held by Scheer Investment Holdings III, LLC. Mr Scheer is the Managing Member of Scheer Investment Holdings III, LLC. and as such may be deemed to have shared voting and investment power with respect to the shares held by Scheer Investment Holdings III, LLC. Mr. Scheer disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
This option was granted on December 18, 2009 and vested over a four year period with 25% of the shares vesting on the first anniversary of the grant date and an additional 6.25% vesting at the end of each three-month period thereafter.